Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0000899243-22-016635 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-04 | 2022-05-02 | VRTX | WAGNER CHARLES F JR | EVP, CFO | S - Sale | $258.83 | -343 | 43.0K | -0.8% | -$88.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-02 | S | D | 48 | $261.15 | 42,765 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $261.15 (range $260.79 to $261.63). |
| 2 | Common | Common Stock | 2022-05-02 | S | D | 3 | $264.37 | 42,730 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-02 | S | D | 32 | $262.06 | 42,733 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $262.06 (range $261.89 to $262.23). |
| 4 | Common | Common Stock | 2022-05-02 | S | D | 20 | $254.87 | 43,053 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-02 | S | D | 80 | $259.45 | 42,813 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $259.45 (range $258.98 to $259.90). |
| 6 | Common | Common Stock | 2022-05-02 | S | D | 60 | $258.21 | 42,893 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $258.21 (range $257.98 to $258.61). |
| 7 | Common | Common Stock | 2022-05-02 | S | D | 100 | $257.18 | 42,953 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $257.18 (range $256.68 to $257.47). (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |